Panna Sharma - 06 Aug 2022 Form 4 Insider Report for Lantern Pharma Inc. (LTRN)

Role
President and CEO, Director
Signature
/s/ Panna Sharma
Issuer symbol
LTRN
Transactions as of
06 Aug 2022
Net transactions value
$0
Form type
4
Filing time
09 Aug 2022, 16:26:49 UTC
Next filing
17 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LTRN Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 06 Aug 2022 Common Stock 100,000 $5.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options will vest and first become exercisable in equal monthly increments over a 36-month period commencing September 8, 2022, with the vesting of the options to accelerate in the event the closing price for our common stock is at least $15.00 per share.